Ai-Min Hui Selected Research

Ai-Min Hui Research Topics

Disease

13	Neoplasms (Cancer) 11/2023 - 05/2002
13	Multiple Myeloma 05/2018 - 01/2009
4	COVID-19 12/2022 - 01/2021
4	Lymphoma (Lymphomas) 10/2016 - 05/2015
3	Thrombocytopenia (Thrombopenia) 01/2022 - 01/2016
3	Peripheral Nervous System Diseases (PNS Diseases) 04/2016 - 12/2014
2	Chronic Renal Insufficiency 09/2022 - 06/2022
2	Immunoglobulin Light-chain Amyloidosis 01/2017 - 01/2015
2	Exanthema (Rash) 04/2016 - 01/2016
2	Breast Neoplasms (Breast Cancer) 06/2008 - 12/2004
2	Glioma (Gliomas) 04/2006 - 12/2004
2	Hepatocellular Carcinoma (Hepatoma) 02/2005 - 11/2004
1	Constipation 01/2024
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2024
1	Anemia 06/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Hematuria 01/2022
1	Hemorrhage 01/2022
1	Hyperbilirubinemia 01/2022
1	Liver Diseases (Liver Disease) 01/2022
1	Proteinuria 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 09/2016
1	Chromosome Aberrations (Chromosome Abnormalities) 04/2016
1	Disease Progression 04/2016
1	Diarrhea 01/2016
1	Fatigue 01/2016
1	Neutropenia 01/2016
1	Hematologic Neoplasms (Hematological Malignancy) 06/2015
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2009
1	Necrosis 06/2008
1	Neoplasm Metastasis (Metastasis) 06/2008
1	Brain Injuries (Brain Injury) 04/2006
1	Carcinoma (Carcinomatosis) 09/2002

Drug/Important Bio-Agent (IBA)

13	Proteasome InhibitorsIBA 01/2017 - 01/2009
13	ixazomibIBA 01/2017 - 08/2014
4	mRNA VaccinesIBA 12/2022 - 01/2021
4	Dexamethasone (Maxidex)FDA LinkGeneric 05/2018 - 12/2014
4	Bortezomib (Velcade)FDA Link 01/2017 - 01/2009
4	Lenalidomide (CC 5013)FDA Link 04/2016 - 08/2014
3	Proteasome Endopeptidase Complex (Proteasome)IBA 06/2015 - 01/2009
2	ferric pyrophosphateIBA 09/2022 - 06/2022
2	Citric Acid (Citrate)FDA LinkGeneric 09/2022 - 06/2022
2	VaccinesIBA 06/2022 - 01/2021
2	Messenger RNA (mRNA)IBA 01/2021 - 11/2004
2	Proteins (Proteins, Gene)FDA Link 02/2005 - 11/2004
1	Sodium-Hydrogen Exchanger 3IBA 01/2024
1	SodiumIBA 01/2024
1	Phosphorus (Red Phosphorus)IBA 01/2024
1	tenapanorIBA 01/2024
1	Immunoconjugates (Immunoconjugate)IBA 11/2023
1	BNT162 VaccineIBA 12/2022
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 10/2022
1	FCN-437cIBA 10/2022
1	RNA (Ribonucleic Acid)IBA 06/2022
1	Cancer VaccinesIBA 06/2022
1	IronIBA 06/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	pretomanidIBA 01/2022
1	avatrombopagIBA 01/2022
1	Uric Acid (Urate)IBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	pomalidomideIBA 05/2018
1	isatuximabIBA 05/2018
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2017
1	CreatinineIBA 09/2016
1	Amyloid (Amyloid Fibrils)IBA 01/2015
1	Thalidomide (Thalomid)FDA Link 08/2014
1	carfilzomibIBA 08/2014
1	marizomibIBA 08/2014
1	Boronic AcidsIBA 01/2009
1	Peptides (Polypeptides)IBA 06/2008
1	PolymersIBA 06/2008
1	IntegrinsIBA 06/2008
1	arginyl-glycyl-aspartic acidIBA 06/2008
1	AH 111585IBA 06/2008
1	Integrin alphaVIBA 06/2008
1	Integrin beta3 (GPIIIa)IBA 06/2008
1	LigandsIBA 06/2008
1	Stem Cell FactorIBA 04/2006
1	Trefoil Factor-3IBA 02/2005
1	AntigensIBA 02/2005
1	Trefoil FactorsIBA 02/2005
1	Selective Estrogen Receptor Modulators (SERM)IBA 12/2004
1	Estrogen ReceptorsIBA 12/2004
1	Tamoxifen FDA LinkGeneric 12/2004
1	CC-8490IBA 12/2004
1	NF-kappa B (NF-kB)IBA 12/2004
1	Ki-67 Antigen (Ki 67 Antigen)IBA 09/2002
1	Cyclin D1IBA 09/2002
1	Cyclin EIBA 09/2002
1	Tumor Biomarkers (Tumor Markers)IBA 05/2002

Therapy/Procedure

6	Therapeutics 06/2022 - 09/2002
2	Renal Dialysis (Hemodialysis) 09/2022 - 06/2022
1	Platelet Transfusion (Blood Platelet Transfusions) 01/2022